$5.60
0.00 (0%)
Indevus Pharmaceuticals (IDEV.DL)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.
No players have picked IDEV.DL yet. Tell us why you think IDEV.DL will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
